Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Appendicitis | 5 | 2019 | 65 | 0.910 |
Why?
|
| Esophageal Atresia | 2 | 2014 | 14 | 0.860 |
Why?
|
| Heart Defects, Congenital | 2 | 2014 | 369 | 0.720 |
Why?
|
| Colostomy | 1 | 2020 | 14 | 0.700 |
Why?
|
| Morals | 1 | 2020 | 97 | 0.630 |
Why?
|
| Hospitals, Pediatric | 4 | 2015 | 125 | 0.630 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 155 | 0.620 |
Why?
|
| Health Information Systems | 2 | 2014 | 7 | 0.540 |
Why?
|
| Infant | 8 | 2020 | 3207 | 0.540 |
Why?
|
| Tracheoesophageal Fistula | 2 | 2014 | 13 | 0.530 |
Why?
|
| Fecal Incontinence | 2 | 2025 | 59 | 0.520 |
Why?
|
| Herniorrhaphy | 2 | 2014 | 88 | 0.510 |
Why?
|
| Constipation | 2 | 2025 | 69 | 0.500 |
Why?
|
| Gastrostomy | 1 | 2015 | 68 | 0.480 |
Why?
|
| Anal Canal | 2 | 2024 | 90 | 0.480 |
Why?
|
| Lumbosacral Plexus | 1 | 2015 | 10 | 0.470 |
Why?
|
| Anorectal Malformations | 2 | 2025 | 5 | 0.460 |
Why?
|
| Intestinal Volvulus | 1 | 2014 | 10 | 0.460 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 49 | 0.450 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2024 | 134 | 0.450 |
Why?
|
| Hirschsprung Disease | 1 | 2014 | 13 | 0.450 |
Why?
|
| Urinary Incontinence | 2 | 2025 | 216 | 0.450 |
Why?
|
| Child, Preschool | 8 | 2015 | 3805 | 0.430 |
Why?
|
| Hernia, Inguinal | 1 | 2014 | 75 | 0.420 |
Why?
|
| Child | 16 | 2025 | 7309 | 0.420 |
Why?
|
| Surgical Procedures, Operative | 2 | 2024 | 210 | 0.420 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2013 | 41 | 0.420 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 114 | 0.410 |
Why?
|
| Fibrosarcoma | 1 | 2013 | 87 | 0.400 |
Why?
|
| Databases, Factual | 2 | 2014 | 955 | 0.390 |
Why?
|
| Wilms Tumor | 1 | 2012 | 36 | 0.380 |
Why?
|
| Organ Sparing Treatments | 1 | 2012 | 47 | 0.380 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2012 | 107 | 0.370 |
Why?
|
| Colon | 1 | 2014 | 527 | 0.350 |
Why?
|
| Biliary Dyskinesia | 2 | 2024 | 3 | 0.350 |
Why?
|
| Cholecystectomy | 2 | 2024 | 24 | 0.340 |
Why?
|
| Infant, Newborn | 6 | 2024 | 2506 | 0.340 |
Why?
|
| Nephrectomy | 1 | 2012 | 294 | 0.320 |
Why?
|
| Treatment Outcome | 13 | 2025 | 8731 | 0.320 |
Why?
|
| Female | 20 | 2022 | 47894 | 0.300 |
Why?
|
| Male | 18 | 2022 | 43928 | 0.280 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 530 | 0.270 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 808 | 0.260 |
Why?
|
| Adolescent | 11 | 2024 | 9495 | 0.260 |
Why?
|
| Humans | 26 | 2025 | 92344 | 0.260 |
Why?
|
| Comorbidity | 3 | 2014 | 986 | 0.250 |
Why?
|
| Retrospective Studies | 9 | 2022 | 9689 | 0.250 |
Why?
|
| Appendectomy | 4 | 2019 | 36 | 0.240 |
Why?
|
| Patient Participation | 2 | 2019 | 227 | 0.240 |
Why?
|
| Postoperative Complications | 4 | 2024 | 2453 | 0.230 |
Why?
|
| Cohort Studies | 4 | 2022 | 2978 | 0.230 |
Why?
|
| Sclerotherapy | 1 | 2024 | 16 | 0.220 |
Why?
|
| Lymphatic Abnormalities | 1 | 2024 | 9 | 0.220 |
Why?
|
| Propensity Score | 2 | 2014 | 164 | 0.210 |
Why?
|
| Morbidity | 2 | 2014 | 157 | 0.210 |
Why?
|
| Combined Modality Therapy | 3 | 2024 | 1733 | 0.190 |
Why?
|
| Abnormalities, Multiple | 2 | 2014 | 236 | 0.190 |
Why?
|
| Reoperation | 2 | 2015 | 653 | 0.190 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 165 | 0.180 |
Why?
|
| Evidence-Based Medicine | 4 | 2025 | 443 | 0.180 |
Why?
|
| Hospital Mortality | 2 | 2014 | 444 | 0.180 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 3776 | 0.180 |
Why?
|
| Public Health | 1 | 2020 | 145 | 0.160 |
Why?
|
| Hospitals | 2 | 2022 | 312 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 290 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2016 | 4471 | 0.130 |
Why?
|
| Fecal Impaction | 1 | 2016 | 4 | 0.130 |
Why?
|
| Gallbladder Emptying | 1 | 2015 | 5 | 0.120 |
Why?
|
| Gallbladder | 1 | 2015 | 32 | 0.120 |
Why?
|
| Second-Look Surgery | 1 | 2014 | 6 | 0.120 |
Why?
|
| Soft Tissue Infections | 1 | 2015 | 26 | 0.120 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2014 | 2 | 0.120 |
Why?
|
| Patient Preference | 1 | 2016 | 120 | 0.120 |
Why?
|
| Tooth Abnormalities | 1 | 2014 | 7 | 0.120 |
Why?
|
| Syndactyly | 1 | 2014 | 13 | 0.120 |
Why?
|
| Abscess | 1 | 2015 | 95 | 0.110 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2014 | 9 | 0.110 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2014 | 17 | 0.110 |
Why?
|
| Risk Adjustment | 1 | 2014 | 40 | 0.110 |
Why?
|
| Ligation | 1 | 2014 | 51 | 0.110 |
Why?
|
| Operative Time | 1 | 2014 | 156 | 0.110 |
Why?
|
| Hearing Loss | 1 | 2014 | 63 | 0.110 |
Why?
|
| Drainage | 1 | 2015 | 168 | 0.110 |
Why?
|
| Lymphoscintigraphy | 1 | 2013 | 5 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2013 | 80 | 0.100 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 71 | 0.100 |
Why?
|
| Multimodal Imaging | 1 | 2013 | 115 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2013 | 123 | 0.100 |
Why?
|
| Philadelphia | 1 | 2012 | 19 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2014 | 672 | 0.100 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2012 | 14 | 0.100 |
Why?
|
| Length of Stay | 2 | 2014 | 790 | 0.090 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 275 | 0.090 |
Why?
|
| Sarcoma | 1 | 2013 | 216 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 498 | 0.090 |
Why?
|
| Surgical Mesh | 1 | 2012 | 124 | 0.090 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2012 | 304 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 279 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2015 | 474 | 0.090 |
Why?
|
| Logistic Models | 1 | 2014 | 1239 | 0.090 |
Why?
|
| Acute Disease | 3 | 2019 | 855 | 0.080 |
Why?
|
| Neoplasms, Second Primary | 1 | 2012 | 245 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 1179 | 0.080 |
Why?
|
| Risk Factors | 2 | 2024 | 5706 | 0.080 |
Why?
|
| Survival Rate | 1 | 2013 | 1926 | 0.080 |
Why?
|
| Hospitalization | 1 | 2014 | 925 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 2035 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2016 | 800 | 0.070 |
Why?
|
| Kidney | 1 | 2012 | 1144 | 0.070 |
Why?
|
| Tertiary Care Centers | 2 | 2019 | 119 | 0.060 |
Why?
|
| United States | 2 | 2022 | 7348 | 0.060 |
Why?
|
| Time Factors | 1 | 2014 | 5429 | 0.060 |
Why?
|
| Ohio | 2 | 2015 | 41 | 0.060 |
Why?
|
| Anus, Imperforate | 1 | 2024 | 11 | 0.060 |
Why?
|
| Rectum | 1 | 2024 | 148 | 0.050 |
Why?
|
| Quality of Life | 2 | 2025 | 1745 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2024 | 448 | 0.040 |
Why?
|
| Incidence | 1 | 2024 | 1661 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1761 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 153 | 0.040 |
Why?
|
| Self Efficacy | 1 | 2019 | 60 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 175 | 0.030 |
Why?
|
| Caregivers | 1 | 2019 | 177 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 259 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 215 | 0.030 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2016 | 5 | 0.030 |
Why?
|
| Piperacillin | 1 | 2016 | 8 | 0.030 |
Why?
|
| Penicillanic Acid | 1 | 2016 | 12 | 0.030 |
Why?
|
| Metronidazole | 1 | 2016 | 26 | 0.030 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2016 | 14 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2016 | 30 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 505 | 0.030 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2015 | 2 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 288 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 217 | 0.030 |
Why?
|
| Sick Leave | 1 | 2014 | 14 | 0.030 |
Why?
|
| Family | 1 | 2016 | 324 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2016 | 247 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2015 | 238 | 0.030 |
Why?
|
| Rosaniline Dyes | 1 | 2013 | 9 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2013 | 65 | 0.030 |
Why?
|
| Rhabdomyosarcoma | 1 | 2013 | 42 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2015 | 707 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 274 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2012 | 9 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 2012 | 74 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 342 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 405 | 0.020 |
Why?
|
| Pediatrics | 1 | 2015 | 369 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2013 | 552 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2016 | 767 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 1920 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2009 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 1180 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2793 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2685 | 0.010 |
Why?
|